US2002106791A1PendingUtilityA1
Beta taipoxin as a cell growth factor and method
Priority: May 3, 1994Filed: Oct 23, 2001Published: Aug 8, 2002
Est. expiryMay 3, 2014(expired)· nominal 20-yr term from priority
Inventors:Binie V. Lipps
A61K 38/00C12N 2501/998C12N 5/0037C07K 14/46
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A peptide containing a sequence for the first fifteen amino acids from the N-terminal of Asn-Leu-Val-Glu-Phe-Gly-Lys-Met-Ile-Glu-Cys-Ala-Ile-Arg-Asn is used in a cell culture medium to promote cell growth in vitro and in the treatment of wounds. A method of preparation of the peptide is also claimed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A culture medium characterized by the presence of a peptide containing a sequence for the first fifteen amino acids from the N-terminal of Asn-Leu-Val-Glu-Phe-Gly-Lys-Met-Ile-Glu-Cys-Ala-Ile-Arg-Asn identified in SEQ ID No: 1.
2 . A culture medium as in claim 1 further characterized in that the peptide comprises beta taipoxin obtained from snake venom.
3 . A culture medium as in claim 2 further characterized in that the beta taipoxin is obtained from the species Oxyuranus s. scutellatus , an Australian taipan snake.
4 . A culture medium as in claim 3 , further characterized by the absence of serum.
5 . A culture medium as in claim 4 further characterized in that the beta taipoxin has a molecular weight of about 14,000 daltons and is present at a concentration in the range of from about 0.1 μg/ml to about 1 μg/ml.
6 . A method for cultivating various types of eukaryotic cells, said method comprising providing a cell culture medium;
placing cells in the cell culture medium; and cultivating said cells, characterized in that the cell culture medium contains a peptide containing a sequence for the first fifteen amino acids from the N-terminal of Asn-Leu-Val-Glu-Phe-Gly-Lys-Met-Ile-Glu-Cys-Ala-Ile-Arg-Asn identified in SEQ ID No: 1.
7 . A method as in claim 6 is further characterized in that the cell culture medium is serum free and the peptide comprises beta taipoxin at a concentration in the range of 0.1 μg/ml to 1 μg/ml.Join the waitlist — get patent alerts
Track US2002106791A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.